Latest Content

Bringing these curative treatments to more patients means making them available at the community practice level. But that's a big lift, according to experts who spoke at a COA session.

A study using Flatiron Health and SEER data shows community oncology patients with metastatic breast cancer and metastatic NSCLC live longer, highlighting COA-backed local care advantages.

Wastewater SARS-CoV-2 levels correlated with hospital COVID-19 cases, supporting targeted screening of asymptomatic patients.

The BCBSNC Foundation's focus on access to care, health through food, and youth mental health aligns with broader national health trends.

The future of specialty pharmacy is not automation alone, but technology designed to assist patients through personalized support.

House lawmakers questioned hospital CEOs over rising health care costs, consolidation, opaque billing, Medicaid cuts, and site neutrality.

Behavioral text nudges outperformed nurse calls, boosting FIT completion by 9 percentage points at an FQHC while saving staff time.

How patient experience and real-world evidence reshape hematology advances in rare disease and blood cancers, beyond clinical end points. This commentary will appear in the May issue of Evidence-Based Oncology.

The entire commercial logic of the pharmaceutical industry’s patient engagement model is built for a moment that no longer exists, according to Chris Moose.